Your greatest defense is within you. Immunocine was founded to bring revolutionary immunotherapy to cancer patients who are not eligible for FDA clinical trials. Our proprietary treatment, Immunocine Dendritic Cell Therapy (IDCT), “double loads” a patient’s dendritic cells with their own cancer cells. This process mimics a viral infection and triggers a powerful, targeted immune response. Backed by 16 years of research and ongoing FDA trials, IDCT offers a less invasive, highly precise option for treating multiple types of cancer. Visit our website to see if you’re eligible to apply for treatment.
Company Details
- Employees
- 9
- Founded
- -
- Address
- Boulevard Luis Donaldo Coloso, Av Tulum Supermanzana 9 Manzana 1 Lote 3, Cancun,q.r 77503,mexico
- Industry
- Medical Practices
- NAICS
-
Ambulatory Health Care ServicesOffices of Other Health PractitionersOutpatient Care CentersOther Ambulatory Health Care ServicesOffices of All Other Health PractitionersOutpatient Mental Health and Substance Abuse CentersAll Other Ambulatory Health Care ServicesOffices of PodiatristsBlood and Organ BanksAll Other Miscellaneous Ambulatory Health Care Services
- Keywords
- Cancer Hospital and Cancer Therapy.
- HQ
- Cancun, Q.R
Immunocine Cancer Center Questions
Immunocine Cancer Center's LinkedIn profile is https://mx.linkedin.com/company/immunocine
Immunocine Cancer Center has
9 employees.
View email and phone details for 9
employees at Immunocine Cancer Center.
Immunocine Cancer Center's industry is
Medical Practices
Immunocine Cancer Center's top competitors are
Cellular Hope Institute,
Hospital Médica Sur,
Azura,
Diakonos Oncology,
American Cancer Society,
Centro Médico Abc,
Medterra,
Bbva En México,
Linde Latam Norte,
Hospitales Mac.
Immunocine Cancer Center's categories are Medical Practices
Immunocine Cancer Center's founding year is 2021
